An Ex Vivo Test of Complement Activation on Endothelium for Individualized Eculizumab Therapy in Hemolytic Uremic Syndrome-Reference-Cited by-同舟云学术

An Ex Vivo Test of Complement Activation on Endothelium for Individualized Eculizumab Therapy in Hemolytic Uremic Syndrome

Published:2019-07 Issue:1 Volume:74 Page:56-72
ISSN:0272-6386
Container-title:American Journal of Kidney Diseases
language:en
Short-container-title:American Journal of Kidney Diseases

Author:

Galbusera Miriam,Noris Marina,Gastoldi Sara,Bresin Elena,Mele Caterina,Breno Matteo,Cuccarolo Paola,Alberti Marta,Valoti Elisabetta,Piras Rossella,Donadelli Roberta,Vivarelli Marina,Murer Luisa,Pecoraro Carmine,Ferrari Elisa,Perna Annalisa,Benigni Ariela,Portalupi Valentina,Remuzzi Giuseppe

Publisher

Elsevier BV

Subject

Nephrology

Reference52 articles.

1. Atypical hemolytic-uremic syndrome;Noris;N Engl J Med,2009

2. Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference;Goodship;Kidney Int,2017

3. Three new cases of late-onset cblC defect and review of the literature illustrating when to consider inborn errors of metabolism beyond infancy;Huemer;Orphanet J Rare Dis,2014

4. Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome;Lemaire;Nat Genet,2013

5. Characterization of a new DGKE intronic mutation in genetically unsolved cases of familial atypical hemolytic uremic syndrome;Mele;Clin J Am Soc Nephrol,2015

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complement system activation: bridging physiology, pathophysiology, and therapy;Intensive Care Medicine;2024-09-10

2. Eculizumab as Salvage Treatment for Thrombotic Microangiopathy After Lung Transplantation;Clinical Transplantation;2024-08-29

3. Exuberant Endothelial C5b-9 Formation in Recurrent and De Novo Posttransplant Thrombotic Microangiopathy;Kidney International Reports;2024-08

4. Ex vivo C5b-9 Deposition Test to Monitor Complement Activity in Clinical and Subclinical Atypical Hemolytic Uremic Syndrome and in Transplantation-Associated Thrombotic Microangiopathy;Kidney International Reports;2024-07

5. A New Approach to Analyze the State of the Complement System in Patients with COVID-19. Pilot Study;Биологические мембраны Журнал мембранной и клеточной биологии;2024-06-14